AbstractAlthough the precise etiologic nature of obsessive-compulsive disorder (OCD), one of the most common psychiatric conditions, is unknown, several findings indicate involvement of the serotonin (5-HT) transporter. Apart from the specific effects of selective 5-HT reuptake inhibitors, other studies show decreased functionality of the platelet 5-HT transporter in OCD. In this report, the authors combine data from two independent studies of patients with OCD, showing both an increased activity of protein kinase type C (PKC) and a decreased activity of protein kinase type A (PKA). The authors propose a unifying hypothesis that OCD might be determined by an imbalance between PKC and PKA, with a prevalence of the former and, more generally, of the phosphoinositide over the cyclic adenosine monophosphate (cAMP) pathway. Should this hypothesis prove correct, the path would be open for new therapeutic interventions in the treatment of OCD.
摘要 虽然强迫症(最常见的精神疾病之一)的确切病因尚不清楚,但一些研究结果表明它与血清素(5-HT)转运体有关。除了选择性 5-HT 再摄取抑制剂的特殊作用外,其他研究显示强迫症患者血小板 5-HT 转运体的功能降低。在这份报告中,作者综合了两项针对强迫症患者的独立研究数据,结果显示 C 型蛋白激酶(PKC)的活性增加,而 A 型蛋白激酶(PKA)的活性降低。作者提出了一个统一的假设,即强迫症可能是由 PKC 和 PKA 之间的失衡决定的,前者占主导地位,更广泛地说,磷脂酰肌醇比环磷酸腺苷(cAMP)途径占主导地位。如果这一假说被证明是正确的,那么治疗强迫症的新疗法干预措施就会出现。